With a history of +75 years, Olyos Group is an international scalable growth platform in Natural & Health nutrition with €130m in Sales, distributed in Pharmacies & Parapharmacies and online.

Olyos Group distinguishes itself as a multi-country growth platform at the forefront of innovation that relies on strong local brands built around strong values (naturalness & performance) and backed by a scientifical and pharmaceutical approach.

Olyos Group’s strategy is supported by 3 main pillars: its organic growth, the consolidation of the European food supplement market and operational excellence with a focus on ESG. The Group has a demonstrated track record of buy&build, with 7 acquisitions realized over the past few years to expand its geographical footprint across Europe.

Olyos is today the number 1 growth performer of the market, has established itself as a key reference partner for pharmacies and has developed a strong e-commerce presence.

It operates two main production sites in Annemasse (France) and Leon (Spain) and counts 500 employees, led by Thierry Verne and Jonathan Bienfait.

In December 2017, Motion Equity Partners invested in Olyos Group, with the ambition to build one of the most sizeable European players in the health nutrition.

Status

Current portfolio

Date of investment

2017

Website

+130
40
23
1

“Olyos Group’s mission is to enhance everyone’s life quality thanks to efficient, innovative and natural solutions. With the support of Motion, we acquired Labcatal, Drasanvi, Stardea and W Group, which perfectly fit with our core values: efficiency, naturality and innovation. Olyos is now a European growth platform with strong international anchorage and a clear ambition to ascend to a top-10 leader in Europe’s natural & health nutrition market.”

Thierry VerneCEO